*Only for medical professionals to read and reference! Another "cross-border"! Abstract: On December 7, 2022, a study published in the journal Neurology showed that cholesterol-lowering drugs are associated with a reduced risk of stroke and cerebral hemorrhage, and that statins a

2025/10/0923:52:35 science 1108

*Only for reading and reference by medical professionals

*Only for medical professionals to read and reference! Another

is "crossing over" again!

Content summary

On December 7, 2022, a study published in the journal "Neurology" showed that cholesterol-lowering drugs are associated with a reduced risk of stroke cerebral hemorrhage Statins are used longer and have a lower risk.

*Only for medical professionals to read and reference! Another

Research screenshot

Current status

David, a member of the University of Southern Denmark Odense and the American Academy of Neurology, is also the author of the study Dr. Gaist said:

  • While statins have been shown to reduce the risk of blood clots in stroke, there have been conflicting studies on whether statin use increases or decreases a person's risk of a first brain bleed;

  • In our study, we looked at the lobes of the brain and non-lobar regions to see if location is a factor in statin use and the risk of first brain hemorrhage;

  • We found that people who used statins had a lower risk of this type of hemorrhagic stroke in two areas of the brain;

  • The risk was even lower with long-term statin use.

Conclusions

This study identified 989 patients with lobar intracerebral hemorrhage (ICH) (52.2% female, mean age 76.3 years) and matched them to 39,500 controls, and 1,175 non-lobar ICH patients (46.5% female, mean age 75.1 years) and matched them to 46,755 controls.

The study found:

  • Current statin use was associated with lower risk of lobar (aOR 0.83) and non-lobar ICH (aOR 0.84);

  • Longer statin use was also associated with lower lobar risk (1 year: aOR 0.89; ≥1 to 5 years aOR 0.89; ≥5 years aOR 0.67; p indicates trend 0.040) and non-large leaf ICH (1 year: aOR1.00; ≥1 to 5 years aOR 0.88; ≥5 years aOR 0.62; p indicates trend 0.001);

  • Estimates stratified by statin intensity were similar to the main estimates for low- and moderate-intensity treatment (lobe aOR 0.82; non-lobe aOR 0.84);

  • The association with high-intensity treatment was neutral.

Outlook

That said, long-term statin use is associated with a lower risk of stroke in two areas of the brain. When taking statins for more than five years, people had a 33% lower risk of stroke in lobar areas of the brain and a 38% lower risk of stroke in non-lobar areas of the brain.

Gaist added:

  • For people taking statins, it is reassuring news that these drugs appear to reduce the risk of bleeding strokes as well as the risk of thrombotic strokes;

  • However, our study was only conducted in a Danish population, mainly people of European ancestry, and more studies should be conducted in other populations in the future.

*Only for medical professionals to read and reference! Another

science Category Latest News